The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Share Class Closures

14 Sep 2021 08:00

RNS Number : 6887L
UBS ETFs
14 September 2021
 

 

14 September 2021

Re: UBS (Irl) ETF Plc (the "Company")

MSCI USA UCITS ETF

S&P 500 UCITS ETF

MSCI Australia UCITS ETF

MSCI United Kingdom IMI Socially Responsible UCITS ETF

Factor MSCI USA Prime Value UCITS ETF

Factor MSCI USA Quality UCITS ETF

Factor MSCI USA Low Volatility UCITS ETF

MSCI USA Select Factor Mix UCITS ETF (the "Funds")

 

Capitalised terms not otherwise defined in this letter have the meaning given to them in the prospectus of the Company and the supplements for the Funds, all dated 23 July 2021 (together, the "Prospectus").

 

Dear Shareholder

 

We are writing to notify you of the decision of the Board of Directors of the Company (the "Board"), to close certain share classes of the Funds (as further detailed below) (the "Share Classes") with effect from 29 October, 2021 (the "Termination Date"), in accordance with the powers provided to the Board in the Constitution. The rationale for the closure of the Share Classes is that the Net Asset Value of each of the Share Classes has fallen below a commercially viable minimum.

 

Fund

Share Class

MSCI USA UCITS ETF

(hedged to GBP) A-dis

S&P 500 UCITS ETF

(hedged to EUR) A-dis

MSCI Australia UCITS ETF

(hedged to GBP) A-dis

MSCI United Kingdom IMI Socially Responsible UCITS ETF

(hedged to USD) A-acc

Factor MSCI USA Prime Value UCITS ETF

(hedged to CHF) A-acc

Factor MSCI USA Quality UCITS ETF

(hedged to CHF) A-acc

Factor MSCI USA Low Volatility UCITS ETF

(hedged to CHF) A-acc

MSCI USA Select Factor Mix UCITS ETF

(hedged to GBP) A-dis

 

From the publication of this notice to Shareholders up until 14 October 2021, Shareholders will be able to exchange their Shares in the normal manner and as is further described in the Prospectus. On the morning of 15 October 2021, the trading of the Shares on the relevant stock exchanges will be suspended. Further information on such suspension will be published by the relevant stock exchanges.

 

Prior to the Termination Date, redemptions will be accepted up and until trade date 25 October 2021 (order entry 25 October 2021 except for MSCI Australia order entry 22 October), in the accordance with the terms and conditions of the Prospectus.

 

Shareholders should note that on the Termination Date, the Company will automatically compulsorily repurchase any remaining shares in the Share Classes. The net proceeds will then be distributed amongst the Shareholders in accordance with their respective shareholdings.

 

For Shareholders on the Primary Market, the Directors will endeavour to settle your repurchase proceeds as soon as possible thereafter and, in any event, no later than 15 November 2021. For Shareholders on the Secondary Market, the time(s) at which any such redemption proceeds are received will depend, among others, on the timeframes and arrangements in place at the respective custodian, broker and/or the relevant settlement system involved for processing of such payments, which in individual cases may take up to a few weeks.

 

The Company will update the Prospectus to reflect the closure of the Share Classes in due course. Expenses relating to the termination of the Share Classes will be borne by the relevant Fund.

 

If you have any queries in relation to the above please contact ol-etf-pfm@ubs.com.

 

 

Yours sincerely,

 

 

_______________________

Director

for and on behalf of

UBS (Irl) ETF Plc

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRGPUUGBUPGUQC
Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.